|
Volumn 45, Issue 12, 2007, Pages 3930-3934
|
Trends in prescribing β-lactam antibiotics for treatment of community-associated methicillin-resistant Staphylococcus aureus infections
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA LACTAM ANTIBIOTIC;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
BACTERIUM ISOLATE;
CHILD;
FEMALE;
HOSPITAL ADMISSION;
HUMAN;
INFANT;
INFECTION RISK;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL RECORD;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
MOLECULAR EPIDEMIOLOGY;
OUTCOME ASSESSMENT;
PRACTICE GUIDELINE;
PRESCRIPTION;
PREVALENCE;
PRIORITY JOURNAL;
RISK ASSESSMENT;
RISK FACTOR;
SKIN INFECTION;
SOFT TISSUE INFECTION;
STAPHYLOCOCCUS INFECTION;
TREATMENT INDICATION;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTI-BACTERIAL AGENTS;
BETA-LACTAMS;
CHILD;
CHILD, PRESCHOOL;
COMMUNITY-ACQUIRED INFECTIONS;
FEMALE;
HEALTH SERVICES RESEARCH;
HUMANS;
INFANT;
INFANT, NEWBORN;
MALE;
METHICILLIN RESISTANCE;
MIDDLE AGED;
PRESCRIPTIONS, DRUG;
PREVALENCE;
STAPHYLOCOCCAL INFECTIONS;
STAPHYLOCOCCUS AUREUS;
UNITED STATES;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
STAPHYLOCOCCUS AUREUS;
|
EID: 37249004270
PISSN: 00951137
EISSN: None
Source Type: Journal
DOI: 10.1128/JCM.01510-07 Document Type: Article |
Times cited : (16)
|
References (29)
|